Personalis, Inc. (PSNL) Stock Forecast
Data as of Jun 17, 2026Healthcare · Current price $9.88 (+0.92%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 26, 2026 | Subbu Nambi | Guggenheim | $13.00 | +31.6% |
| Dec 1, 2025 | Kallum Titchmarsh | Morgan Stanley | $11.00 | +11.3% |
| Nov 5, 2025 | Thomas Flaten | Lake Street | $11.00 | +11.3% |
| Nov 5, 2025 | Mike Matson | Needham | $10.00 | +1.2% |
| Aug 6, 2025 | Mark Massaro | BTIG | $6.00 | -39.3% |
| Aug 19, 2024 | Thomas Flaten | Lake Street | $8.00 | -19.0% |
| Aug 19, 2024 | Swayampakula Ramakanth | H.C. Wainwright | $9.00 | -8.9% |
| Aug 16, 2024 | Mark Massaro | BTIG | $7.00 | -29.1% |
| Aug 8, 2024 | Mark Massaro | BTIG | $5.50 | -44.3% |
| Aug 8, 2024 | Mike Matson | Needham | $5.50 | -44.3% |
| Jun 21, 2024 | Mike Matson | Needham | $3.50 | -64.6% |
| Apr 30, 2024 | Thomas Flaten | Loop Capital Markets | $4.00 | -59.5% |
Top Analysts Covering PSNL
PSNL vs Sector & Market
| Metric | PSNL | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.29 | 2.24 | 2.40 |
| Analyst Count | 7 | 8 | 19 |
| Target Upside | +15.3% | +11475.0% | +17.1% |
| P/E Ratio | -6.25 | 3.92 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $16M | $17M | $18M | 4 |
| 2026-09-30 | $21M | $23M | $25M | 2 |
| 2026-12-31 | $23M | $24M | $26M | 3 |
| 2027-03-31 | $21M | $22M | $24M | 3 |
| 2027-06-30 | $24M | $26M | $28M | 2 |
| 2027-09-30 | $29M | $31M | $34M | 2 |
| 2027-12-31 | $31M | $34M | $36M | 3 |
| 2028-12-31 | $159M | $159M | $159M | 2 |
| 2029-12-31 | $173M | $181M | $186M | 1 |
| 2030-12-31 | $213M | $223M | $229M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.30 | $-0.27 | $-0.25 | 3 |
| 2026-09-30 | $-0.29 | $-0.26 | $-0.24 | 1 |
| 2026-12-31 | $-0.31 | $-0.27 | $-0.25 | 1 |
| 2027-03-31 | $-0.30 | $-0.27 | $-0.25 | 1 |
| 2027-06-30 | $-0.27 | $-0.24 | $-0.22 | 1 |
| 2027-09-30 | $-0.25 | $-0.23 | $-0.21 | 1 |
| 2027-12-31 | $-0.25 | $-0.22 | $-0.20 | 1 |
| 2028-12-31 | $-0.55 | $-0.53 | $-0.51 | 2 |
| 2029-12-31 | $-0.13 | $-0.13 | $-0.12 | 1 |
| 2030-12-31 | $-0.02 | $-0.02 | $-0.02 | 1 |
Frequently Asked Questions
What is the analyst consensus for PSNL?
The consensus among 7 analysts covering Personalis, Inc. (PSNL) is Buy with an average price target of $11.00.
What is the highest price target for PSNL?
The highest price target for PSNL is $13.00, set by Subbu Nambi at Guggenheim on 2026-01-26.
What is the lowest price target for PSNL?
The lowest price target for PSNL is $3.50, set by Mike Matson at Needham on 2024-06-21.
How many analysts cover PSNL?
7 analysts have issued ratings for Personalis, Inc. in the past 12 months.
Is PSNL a buy or sell right now?
Based on 7 analyst ratings, PSNL has a consensus rating of Buy (2.29/5) with a +15.3% upside to the consensus target of $11.00.
What are the earnings estimates for PSNL?
Analysts estimate PSNL will report EPS of $-0.27 for the period ending 2026-06-30, with revenue estimated at $17M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.